Brielle Benyon - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Brielle Benyon's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Brielle Benyon
Verified
Assistant Managing Editor, CURE Magazine
New Jersey
Beats
Mental Health
Nothing.
Content
By Brielle Benyon Verified| Targeted Oncology Verified AFTER 8.4 years of follow-up, ado-trastuzumab emtansine (T-DM1; Kadcyla) led to improved overall survival (OS) and invasive disease–free survival (iDFS) over trastuzumab (Herceptin) in patients with HER2-positive early breast cancer who had residual invasive disease after neoadjuvant therapy, according to findings from the KATHERINE trial (NCT01772472) that were presented at the 2024 San Antonio Breast Cancer Symposium in Texas.
By Brielle Benyon Verified| OncLive Verified For Edward S. Kim, MD, much of his life revolved around rewriting the rules both professionally and personally. Those in the oncology space might know him as the man working tirelessly to improve clinical trial access or leading several practice-changing research studies, including the BATTLE trial’s (NCT00409968) landmark research that laid the groundwork for the use of biomarkers to personalize lung cancer care.
By Brielle Benyon Verified| Targeted Oncology Verified AFTER 8.4 years of follow-up, ado-trastuzumab emtansine (T-DM1; Kadcyla) led to improved overall survival (OS) and invasive disease–free survival (iDFS) over trastuzumab (Herceptin) in patients with HER2-positive early breast cancer who had residual invasive disease after neoadjuvant therapy, according to findings from the KATHERINE trial (NCT01772472) that were presented at the 2024 San Antonio Breast Cancer Symposium in Texas.
Company Info
CURE Magazine
Curetoday.com and CURE magazine, our free publication, are the leading resources for patients with cancer, survivors and their caregivers to become empowered advocates in their journeys. We deliver cancer updates, research and education to help make cancer understandable during every stage of the experience and connect the cancer community.
'+1 609-716-7777
Founded: 2002